Movement Alert｜CANSINOBIO Intraday Rise 5.42% in Regular Trading, biotech sector strength and recent third-quarter growth supported sentiment

Market Focus

Nov 05

On November 5, CANSINOBIO rose 5.42% in regular trading, trading at HK$27.42, with turnover of HK$37.61 million.

The move aligned with continued strength across Hong Kong biotech stocks, with BEONE MEDICINES up 5.1%, INNOVENT BIO up 4.0%, AKESO up 3.76%, SKB BIO up 5.92%, and 3SBIO up 5.02%.

On the company side, CANSINOBIO reported third-quarter results on October 27 showing revenue of RMB882 million for the first nine months, up 27.40% year over year, while attributable net profit rose 12.82% to RMB16.29 million. Third-quarter revenue was RMB332 million, up 7.17% year over year. These figures provided recent fundamental support to sentiment as the sector advanced.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1162778114"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162778114\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162778114?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-11-05 09:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162778114","market":"hk","top_or_hot":-1,"title":"Movement Alert｜CANSINOBIO Intraday Rise 5.42% in Regular Trading, biotech sector strength and recent third-quarter growth supported sentiment","media":"Market Focus","content":"<p><p>On November 5, CANSINOBIO rose 5.42% in regular trading, trading at HK$27.42, with turnover of HK$37.61 million.</p><p>The move aligned with continued strength across Hong Kong biotech stocks, with BEONE MEDICINES up 5.1%, INNOVENT BIO up 4.0%, AKESO up 3.76%, SKB BIO up 5.92%, and 3SBIO up 5.02%.</p><p>On the company side, CANSINOBIO reported third-quarter results on October 27 showing revenue of RMB882 million for the first nine months, up 27.40% year over year, while attributable net profit rose 12.82% to RMB16.29 million. Third-quarter revenue was RMB332 million, up 7.17% year over year. These figures provided recent fundamental support to sentiment as the sector advanced.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜CANSINOBIO Intraday Rise 5.42% in Regular Trading, biotech sector strength and recent third-quarter growth supported sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜CANSINOBIO Intraday Rise 5.42% in Regular Trading, biotech sector strength and recent third-quarter growth supported sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-11-05 09:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On November 5, CANSINOBIO rose 5.42% in regular trading, trading at HK$27.42, with turnover of HK$37.61 million.</p><p>The move aligned with continued strength across Hong Kong biotech stocks, with BEONE MEDICINES up 5.1%, INNOVENT BIO up 4.0%, AKESO up 3.76%, SKB BIO up 5.92%, and 3SBIO up 5.02%.</p><p>On the company side, CANSINOBIO reported third-quarter results on October 27 showing revenue of RMB882 million for the first nine months, up 27.40% year over year, while attributable net profit rose 12.82% to RMB16.29 million. Third-quarter revenue was RMB332 million, up 7.17% year over year. These figures provided recent fundamental support to sentiment as the sector advanced.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06185","symbol_name":"康希诺生物","start_time":0,"source_url":"","article_id":"1162778114","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162778114","pubTimestamp":1793843007,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On November 5, CANSINOBIO rose 5.42% in regular trading, trading at HK$27.42, with turnover of HK$37.61 million.The move aligned with continued strength across Hong Kong biotech stocks, with BEONE...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06185":"康希诺生物"},"translate_title":"走势提醒|康希诺生物常规交易盘中上涨5.42%，生物技术板块走强和近期第三季度增长支撑情绪","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06185":1},"content_text":"On November 5, CANSINOBIO rose 5.42% in regular trading, trading at HK$27.42, with turnover of HK$37.61 million.The move aligned with continued strength across Hong Kong biotech stocks, with BEONE MEDICINES up 5.1%, INNOVENT BIO up 4.0%, AKESO up 3.76%, SKB BIO up 5.92%, and 3SBIO up 5.02%.On the company side, CANSINOBIO reported third-quarter results on October 27 showing revenue of RMB882 million for the first nine months, up 27.40% year over year, while attributable net profit rose 12.82% to RMB16.29 million. Third-quarter revenue was RMB332 million, up 7.17% year over year. These figures provided recent fundamental support to sentiment as the sector advanced.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}